| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $45.2M | — | +40.1% |
| Gross Profit | $19.2M | — | +39.5% |
| R&D Expense | $1.4M | — | +78.2% |
| SG&A Expense | $11.7M | — | +26.1% |
| Operating Income | -$1.8M | — | +55.0% |
| Pre-tax Income | $18.1M | — | +149.6% |
| Income Tax | $2.4M | — | +633.6% |
| Net Income | $13.8M | — | +124.6% |
| EPS (Basic) | $0.04 | — | +100.0% |
| EPS (Diluted) | $0.04 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $821.9M | +3.8% | +3.0% |
| Short-term Investments | $0 | -100.0% | -100.0% |
| Accounts Receivable | $33.0M | -3.3% | +76.1% |
| Inventory | $48.7M | +4.1% | +40.7% |
| Current Assets | $927.9M | -1.7% | +1.0% |
| Total Assets | $1.17B | -2.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $10.9M | — | +619.9% |
| Capital Expenditures | $1.9M | — | -87.7% |
| Investing Cash Flow | $38.0M | — | +168.7% |
| Financing Cash Flow | -$18.3M | — | -523.5% |
| Free Cash Flow | $9.0M | — | +152.0% |
| +1.6% |
| Current Liabilities | $42.4M | -12.0% | +28.4% |
| Total Liabilities | $48.3M | -10.9% | +23.6% |
| Stockholders' Equity | $1.07B | -1.8% | +0.7% |